Starling Oncology, Inc.
DFPH- Exchange
- OTC
- Industry
- Services-Offices & Clinics of Doctors of Medicine
- SEC CIK
- 0001799191
In the last 90 days, Starling Oncology, Inc. insiders filed 3 open-market purchases and 2 sales; no institution reported holding it in 13F filings for Q2 2026; no superinvestor holds it.
13F holders, Q4 2021
Institutional positions in Starling Oncology, Inc. as of Dec 31, 2021. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 0
- −49 vs. Q3 2021
- Shares held
- 0
- −21.0M (−100.0%) vs. Q3 2021
- Total value
- $0
- −$209.1M (−100.0%) vs. Q3 2021
- New holders
- 0
- 0 more added
- Sold out
- 49
- 0 more reduced
1 institution that held it in Q3 2021 haven't filed for Q4 2021 yet. Not filing isn't selling, so they aren't counted as sold out or in the changes above.
Compare with Q3 2021: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting DFPH on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 0 | $0 |
| Q1 2026 | 0 | $0 |
| Q4 2025 | 0 | $0 |
| Q3 2025 | 0 | $0 |
| Q2 2025 | 0 | $0 |
| Q1 2025 | 0 | $0 |
| Q4 2024 | 0 | $0 |
| Q3 2024 | 0 | $0 |
| Q2 2024 | 0 | $0 |
| Q1 2024 | 0 | $0 |
| Q4 2023 | 0 | $0 |
| Q3 2023 | 0 | $0 |
| Q2 2023 | 0 | $0 |
| Q1 2023 | 0 | $0 |
| Q4 2022 | 1 | $15 |
| Q3 2022 | 0 | $0 |
| Q2 2022 | 0 | $0 |
| Q1 2022 | 0 | $0 |
| Q4 2021 | 0 | $0 |
| Q3 2021 | 50 | $216.7M |
| Q2 2021 | 53 | $214.7M |
| Q1 2021 | 50 | $260.6M |
Institutions, Q4 2021
Shares, value and share of portfolio for each institution holding Starling Oncology, Inc.; share changes are against Q3 2021.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Deerfield Management Company, L.P. (Series C) | 0 | $0 | 0.00% | −5,000,000−100.0% | Sold out |
| Millennium Management LLC | 0 | $0 | 0.00% | −1,582,630−100.0% | Sold out |
| Citadel Advisors LLC | 0 | $0 | 0.00% | −1,467,184−100.0% | Sold out |
| Davidson Kempner Capital Management LP | 0 | $0 | 0.00% | −1,274,555−100.0% | Sold out |
| Weiss Asset Management LP | 0 | $0 | 0.00% | −1,235,168−100.0% | Sold out |
| 683 Capital Management, LLC | 0 | $0 | 0.00% | −1,000,000−100.0% | Sold out |
| Magnetar Financial LLC | 0 | $0 | 0.00% | −913,355−100.0% | Sold out |
| TIG Advisors, LLC | 0 | $0 | 0.00% | −852,706−100.0% | Sold out |
| Westchester Capital Management, LLC | 0 | $0 | 0.00% | −548,090−100.0% | Sold out |
| Wolverine Asset Management LLC | 0 | $0 | 0.00% | −520,184−100.0% | Sold out |
| Deutsche Bank AG | 0 | $0 | 0.00% | −500,000−100.0% | Sold out |
| UBS Oconnor LLC | 0 | $0 | 0.00% | −499,982−100.0% | Sold out |
| Bank of America Corp | 0 | $0 | 0.00% | −462,000−100.0% | Sold out |
| JPMorgan Chase & Co | 0 | $0 | 0.00% | −461,620−100.0% | Sold out |
| HBK Investments L P | 0 | $0 | 0.00% | −450,000−100.0% | Sold out |
| Man Group plc | 0 | $0 | 0.00% | −378,963−100.0% | Sold out |
| Radcliffe Capital Management, L.P. | 0 | $0 | 0.00% | −349,900−100.0% | Sold out |
| CSS LLC | 0 | $0 | 0.00% | −307,988−100.0% | Sold out |
| Bulldog Investors, LLP | 0 | $0 | 0.00% | −307,288−100.0% | Sold out |
| Healthcare of Ontario Pension Plan Trust Fund | 0 | $0 | 0.00% | −300,341−100.0% | Sold out |
| Glazer Capital, LLC | 0 | $0 | 0.00% | −266,085−100.0% | Sold out |
| Moore Capital Management, LP | 0 | $0 | 0.00% | −250,000−100.0% | Sold out |
| Alyeska Investment Group, L.P. | 0 | $0 | 0.00% | −235,448−100.0% | Sold out |
| Beryl Capital Management LLC | 0 | $0 | 0.00% | −197,924−100.0% | Sold out |
| Castle Creek Arbitrage, LLC | 0 | $0 | 0.00% | −163,847−100.0% | Sold out |
| Picton Mahoney Asset Management | 0 | $0 | 0.00% | −150,000−100.0% | Sold out |
| Vivaldi Asset Management, LLC | 0 | $0 | 0.00% | −149,344−100.0% | Sold out |
| Tenor Capital Management Co., L.P. | 0 | $0 | 0.00% | −140,287−100.0% | Sold out |
| D. E. Shaw & Co., Inc. | 0 | $0 | 0.00% | −124,360−100.0% | Sold out |
| Falcon Edge Capital, LP | 0 | $0 | 0.00% | −117,450−100.0% | Sold out |
| Deltec Asset Management LLC | 0 | $0 | 0.00% | −100,000−100.0% | Sold out |
| Saba Capital Management, L.P. | 0 | $0 | 0.00% | −95,685−100.0% | Sold out |
| Fortress Investment Group LLC | 0 | $0 | 0.00% | −86,056−100.0% | Sold out |
| Schonfeld Strategic Advisors LLC | 0 | $0 | 0.00% | −76,174−100.0% | Sold out |
| CNH Partners LLC | 0 | $0 | 0.00% | −71,760−100.0% | Sold out |
| Periscope Capital Inc. | 0 | $0 | 0.00% | −69,604−100.0% | Sold out |
| DuPont Capital Management Corp | 0 | $0 | 0.00% | −50,000−100.0% | Sold out |
| Berkley W R Corp | 0 | $0 | 0.00% | −49,060−100.0% | Sold out |
| P Schoenfeld Asset Management LP | 0 | $0 | 0.00% | −47,294−100.0% | Sold out |
| Baird Financial Group, Inc. | 0 | $0 | 0.00% | −46,000−100.0% | Sold out |
| Q Global Advisors, LLC | 0 | $0 | 0.00% | −40,000−100.0% | Sold out |
| Nomura Holdings Inc | 0 | $0 | 0.00% | −33,500−100.0% | Sold out |
| UBS Group AG | 0 | $0 | 0.00% | −30,443−100.0% | Sold out |
| Goldman Sachs Group Inc | 0 | $0 | 0.00% | −16,772−100.0% | Sold out |
| Captrust Financial Advisors | 0 | $0 | 0.00% | −15,829−100.0% | Sold out |
| Exos Asset Management LLC | 0 | $0 | 0.00% | −5,000−100.0% | Sold out |
| Penserra Capital Management LLC | 0 | $0 | 0.00% | −3,955−100.0% | Sold out |
| Royal Bank of Canada | 0 | $0 | 0.00% | −2,580−100.0% | Sold out |
| Tower Research Capital LLC (TRC) | 0 | $0 | 0.00% | −452−100.0% | Sold out |
| Omni Partners US LLC | – | – | – | – | Not filed |